Alder BioPharmaceuticals(R) announces first quarter 2017 financial results
Alder BioPharma reported the net loss for the 2017 first quarter totaled $100.3 million, or $2.00 per share, versus a net loss of $33.4 million, or $0.76 per share, for the same 2016 period. As of March 31, 2017, Alder had $289.6 million in cash and equivalents. April 27, 2017